Eilat IX

Scheduled for June 15 - 19, 2008, this conference program provided an in-depth progress report on new antiepileptic drugs in different stages of development, as well as to present new findings on second-generation treatments. The Epilepsy Therapy Project is proud to have been a co-sponsor of this conference with The Hebrew University of Jerusalem. Read more.

Epilepsy Pipeline Update: Portal into CNS Opportunities

Read the President's Report on the Conference

Conference Webcasts and Abstracts

Continuing the tradition of the Antiepileptic Drug Conferences (AED I-IX) but with a focus on drug development strategies, investing and business development opportunities, this invitation-only, in-depth, one-day forum on March 13th, 2008, provided an opportunity for emerging CNS companies and scientific entrepreneurs to present their strategies, product candidates and development programs to potential venture capital, private equity, pharma and biotech investors and partners. Read more.

Antiepileptic Drug Trials IX

In 2007 as many antiepileptic drugs are in the pipeline as at any time in the past. With nine new AEDs already approved, there is a unique opportunity to learn from the past as we move into the future. The AED IX symposium brings together representatives from academia, industry, the NIH, and the FDA to review what has been learned and to discuss strategies to enhance AED development. The Epilepsy Therapy Project is proud to be a co-sponsor with the University of Pennsylvania of AED IX. Read more.

Webcasts

Antiepileptic Drug Trials IX

The ninth biannual conference sponsored by the University of Pennsylvania Medical Center and the Epilepsy Therapy Project was held in Sunny Isles, Florida, March 21 – 23, 2007. The focus was on issues related to antiepileptic drug (AED) development from preclinical discoveries through clinical evaluations. Read more.

Special Interest Groups (SIGs): 2005 AES Annual Meeting

The Epilepsy Therapy Project continues to support educational and research issues, and is pleased to provide a selection of presentations available by webcast. The next best thing to being there. Read more.